Asia Pacific Medical Endoscopes Market Outlook (2021-2031)

The Asia Pacific medical endoscopes market is projected to grow significantly, reaching an estimated size of US$ 5,511.79 million by 2031, up from US$ 3,115.42 million in 2024. The market is expected to record a compound annual growth rate (CAGR) of 8.5% from 2025 to 2031.

Executive Summary and Market Analysis:

Several factors are driving the increasing demand for medical endoscopes in the Asia Pacific region. These include a large and diverse population, a rise in chronic diseases such as cancer, gastrointestinal disorders, and neurological conditions, and a growing elderly demographic.

Asia Pacific is the fastest-growing region in the medical endoscope market, propelled by rapid healthcare development, heightened patient awareness, and a growing preference for minimally invasive procedures. Key countries like China, India, Japan, South Korea, and Australia are leading this growth due to their substantial patient populations, expanding hospital networks, and increased investments in medical technology. As healthcare infrastructure modernizes and affordability improves, the Asia Pacific region is expected to play a significant role in shaping the global demand and innovation in medical endoscopes.

Market Segmentation Analysis:

The analysis of the medical endoscopes market is segmented by product type, usability, application, and end user.

Product Type:The market is divided into rigid endoscopes, flexible endoscopes, capsule endoscopes, ultrasound endoscopes, and robot-assisted endoscopes. The flexible endoscopes segment dominated the market in 2024.

Usability:The market is further classified into reusable and disposable endoscopes, with reusable endoscopes holding the largest share in 2024.

Application:The market includes gastrointestinal endoscopy, laparoscopy, gynecological endoscopy, arthroscopy, uroscopy, bronchoscopy, ENT endoscopy, neuroendoscopy, and others. The gastrointestinal endoscopy segment accounted for the largest share in 2024.

End User:The market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and diagnostic centers, with hospitals holding the largest market share in 2024.

Market Outlook:

The development of healthcare infrastructure is significantly contributing to the growth of the medical endoscope market in the Asia Pacific. Rapid investments in emerging economies like India, China, Vietnam, and Indonesia are enhancing access to quality healthcare services. These countries are witnessing a surge in the number of hospitals, specialty clinics, and diagnostic centers, many of which are equipped to perform advanced endoscopic procedures.

This expansion is improving patient access to minimally invasive diagnostics and treatments, leading to increased procedural volumes. International medical device companies are also expanding their presence to meet this growing demand. For example, in July 2024, FUJIFILM India inaugurated its second-largest service center in Mumbai to expedite repairs of gastroscopes and bronchoscopes. This initiative aims to reduce turnaround times and enhance service efficiency across India, thereby supporting endoscope adoption.

Country Insights:

The Asia Pacific medical endoscopes market is segmented into various regions, including China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh, and the rest of Asia. In 2024, China held the largest market share.

The medical endoscope market in China is growing rapidly due to extensive healthcare reforms, rising healthcare expenditures, and a burgeoning middle class seeking higher standards of care. The increasing prevalence of gastrointestinal, respiratory, and urological disorders, particularly among the aging population, is significantly boosting demand for endoscopic procedures.

A major driver of growth is the frequent introduction of advanced endoscopic technologies by global companies and rapidly evolving domestic manufacturers. For instance, in November 2023, Olympus Corporation launched its next-generation EVIS X1 endoscopy system in China. This system features advanced imaging technologies designed to improve the visibility of lesions and polyps, thus enhancing diagnostic accuracy and patient outcomes.

Company Profiles:

Key players in the Asia Pacific medical endoscopes market include Olympus Corporation, Johnson & Johnson, Karl Storz SE & Co. KG, Smith+Nephew, Medtronic, Boston Scientific, B. Braun SE, Stryker Corporation, FUJIFILM Holdings Corporation, HOYA Corporation, and Ambu A/S. These companies adopt various strategies, including expansion, product innovation, and mergers and acquisitions, to maintain competitiveness and provide innovative products to their customers. Show more